“Concurrent EGFR and KRAS Mutations in Non-Small Cell Lung Cancer: Challenging the Paradigm of Linear Targeted Therapy”. 2025. Journal of Current Biomedical Reports 6 (2): 45-46. https://doi.org/10.61882/jcbior.6.2.299.